References
Fulton B, Brogden RN. Buspirone: an updated review of its clinical pharmacology and therapeutic applications. CNS Drugs 1997; 7: 68–88
Martindale. The Extra Pharmacopoeia, 31th ed. London: Pharmaceutical Press, 1996
Sacchetti E, Zerbini O, Banfi F. Overlap of buspirone with lorazepam, diazepam and bromazepam in patients with generalized anxiety disorder: findings from a controlled, multicentre, double-blind study. Hum Psychopharmacol 1994 Nov-Dec; 9: 409–22
Goldberg HL, Finnerty R. Comparison of buspirone in two separate studies. J Clin Psychiatry 1982 Dec; 43 (12): 87–91
Cohn JB, Rickels K. A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety. Curr Med Res Opin 1989; 11: 304–20
Feighner JP, Merideth CH, Hendrickson GA. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J Clin Psychiatry 1982 Dec; 43 (12): 103–7
Pecknold JC, Matas M, Howarth BG, et al. Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo. Can J Psychiatry 1989 Nov; 34: 766–71
Rickels K, Weisman K, Norstad N, et al. Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry 1982 Dec; 43 (12): 81–6
Wheatley D. Buspirone: multicenter efficacy study. J Clin Psychiatry 1982 Dec; 43 (12): 92–4
Strand M, Hetta J, Rosen A, et al. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam. J Clin Psychiatry 1990 Sep; 51 Suppl.: 40–5
Fabre LF. Buspirone in the management of major depression: a placebo-controlled comparison. J Clin Psychiatry 1990 Sep; 51 Suppl.: 55–61
Rickels K, Amsterdam JD, Clary C. Buspirone in major depression: a controlled study. J Clin Psychiatry 1991 Jan; 52: 34–8
Sramek JJ, Tansman M, Suri A, et al. Efficacy of bus pirone in generalised anxiety disorder with coexisting mild depressive symptoms. J Clin Psychiatry 1996; 57: 287–91
Robinson DS, Rickels K, Feighner J, et al. Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 1990 Jun; 10 Suppl.: 67–76
Package Insert, Mead Johnson Pharmaceuticals, A Division Bristol-Myers Squibb, Princeton, New Jersey, USA. 1995 January
British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar
1995 Physicians GenRx. St Louis, Missouri: Mosby-Year Book, Inc., 1995
Rights and permissions
About this article
Cite this article
Buspirone: An Alternative to Benzodiazepines in Anxiety-Related Disorders. Drugs Ther. Perspect 9, 1–5 (1997). https://doi.org/10.2165/00042310-199709100-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199709100-00001